Sign in

CIK 0000879169

  • Large accelerated filer

INCYTE CORP

Sign in to watch
Ticker
INCY
Exchange
Nasdaq
Industry
Services-Commercial Physical & Biological Research
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943136539
Phone
+1 302-498-6700
Business address
1801 AUGUSTINE CUT-OFF, WILMINGTON, DE, 19803
Former names
INCYTE INC, INCYTE GENOMICS INC, INCYTE PHARMACEUTICALS INC
  1. 4 Planned sale EVP & General Counsel sold 277 shares at $85.13 ($23,581)
  2. 4 Planned sale EVP & General Counsel sold 4,100 shares at an average $85.85 ($351,978)
  3. 4 Shares withheld for taxes EVP & Chief Scientific Officer gave up 1,569 shares (to pay taxes)
  4. 4 Shares withheld for taxes EVP, Head of Incyte Intl gave up 463 shares (to pay taxes)
  5. 4 Grant or award Director acquired 776 shares (grant or award)
  6. 4 Grant or award Director acquired 285 shares (grant or award)
  7. 4 Grant or award Director acquired 289 shares (grant or award)
  8. 4 Grant or award EVP, Chief Strategy Officer acquired 9,429 shares (grant or award)
  9. 3 Insider Initial Statement of Ownership
  10. 4 Planned sale EVP & General Counsel sold 278 shares at $83.15 ($23,116)
  11. 4 Planned sale EVP & General Counsel sold 598 shares at $84.97 ($50,812)
  12. 4 Grant or award EVP, Human Resources acquired 6,506 shares (grant or award)
  13. 3 Insider Initial Statement of Ownership
  14. 4 Planned sale EVP & General Counsel sold 277 shares at $86.81 ($24,046)
  15. 4 Planned sale EVP & General Counsel sold 598 shares at $75.77 ($45,310)
  16. 3 Insider Initial Statement of Ownership
  17. 4 Planned sale EVP & Chief Medical Officer sold 3,706 shares at $67.94 ($251,786)
  18. 4 Planned sale EVP & General Manager US sold 1,340 shares at $68.36 ($91,602)
  19. 4 Planned sale EVP, GMAPPS sold 983 shares at $68.36 ($67,198)
  20. 4 Planned sale EVP & General Counsel sold 4,115 shares at an average $69.57 ($286,296)

Page 6 of 82 · 1,628 filings